New Zealand cancels 2021 APEC summit, will lead it virtually

New Zealand was scheduled to host the Asia-Pacific Economic Cooperation forum in Auckland. The event would have brought thousands of people to the country throughout the year, culminating in a leader's week in November 2021.

PTI

June 30, 2020 / 09:17 AM IST

Representative Image

New Zealand on Tuesday canceled its plans to host a major meeting of U.S. and Asian leaders next year because of the coronavirus, opting instead to lead a virtual summit.

New Zealand was scheduled to host the Asia-Pacific Economic Cooperation forum in Auckland. The event would have brought thousands of people to the country throughout the year, culminating in a leader's week in November 2021.

APEC focuses on trade issues, although it also provides a chance for world leaders to catch up. Its 21 members include the U.S., China, Japan, South Korea, Mexico, Indonesia and Hong Kong.

Last year, Chile canceled the APEC leaders' meeting because of violent anti-government protests. This year Malaysia has been hosting virtual APEC meetings. New Zealand's Deputy Prime Minister Winston Peters said it was necessary to cancel next year's summit now for planning and security reasons.

“There were people who would be coming in months and months in advance, all caught by the COVID-19 situation," Peters said.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show